Athena Global Technologies Ltd

Meeting Details

• Board meeting on 14 August 2026 at the registered office; time not disclosed.

Key Agenda Items

• Consider and approve unaudited standalone and consolidated financial results for Q1 ended 30 June 2026.

Other Notes

• Trading window closed from 01 July 2026 till 48 hours after results for designated persons and connected parties.

Certificate submission status

• RTA has issued a certificate confirming Reg 74(5) compliance for the quarter.

Financial results

• Approved audited standalone and consolidated results for Q4 and FY ended 31 March 2026.

Auditor opinion

• Statutory auditors issued unmodified opinions on standalone and consolidated audited results for FY 2025-26.

Internal auditor appointment

• Appointed M/s. Sarda & Agarwal, Chartered Accountants, as internal auditors for FY 2026-27.
• Appointment effective 30 May 2026, as recommended by the Audit Committee.

Investment approval

• Approved investment up to ₹50 crore in OCDs of Medley Medical Solutions and Tutoroot Technologies.
• Investment may be made in one or more tranches.

Meeting Details

• Board meeting scheduled for 30 May 2026.
• Meeting time was not disclosed.
• Meeting to be held at the registered office of the company.

Key Agenda Items

• Approve audited standalone and consolidated financial results for Q4 and year ended 31 March 2026.

Other Notes

• Trading window closed from 1 April 2026 until 48 hours after results announcement.

Purpose of EGM

• Issuance of up to 700,000 warrants convertible into equity shares to promoter
• Re-appointment of Mr. M. Satyendra as Chairman & Managing Director
• Approval for material related party transactions with Medley Medical Solutions Pvt Ltd

Summary of Resolutions

• Resolution 1: Special resolution for preferential issuance of 700,000 warrants to promoter
• Resolution 2: Special resolution for re-appointment of Mr. M. Satyendra as CMD
• Resolution 3: Ordinary resolution for approval of material related party transactions

Voting Outcome

• All three resolutions passed with 100% votes in favor and no votes against
• Total votes cast were 10,294,745 representing 69.98% of outstanding shares
• No invalid votes reported for any resolution

Impact on Shareholding/Control

• Preferential allotment of warrants to promoter likely to increase promoter shareholding
• Re-appointment of CMD maintains existing management control
• Related party transaction approval does not affect shareholding or control

Board/Management Changes

• Re-appointment of Mr. M. Satyendra as Chairman & Managing Director confirmed

Purpose of EGM

• Issue up to 700,000 convertible warrants to promoters on preferential basis
• Re-appoint M. Satyendra as Chairman & Managing Director
• Approve material related party transactions with Medley Medical Solutions Pvt Ltd

Summary of Resolutions

• Special resolution for preferential issue of 700,000 warrants to promoters
• Special resolution for re-appointment of M. Satyendra as Chairman & MD
• Ordinary resolution for approval of related party transactions with Medley Medical Solutions

Meeting and Voting

• All resolutions were put to remote e-voting prior to meeting
• Insta-poll voting facility provided during EGM for remaining members
• Scrutinizer appointed to supervise e-voting process

Board and Management Attendance

• All directors and key management personnel attended via video conferencing
• M. Satyendra chaired the meeting
• Company Secretary Gayathri Prithviraj conducted proceedings

Purpose of Corrigendum

• Corrigendum issued to amend EGM Notice dated March 2, 2026
• Includes disclosure of pre-issue and post-issue share capital details
• Adds percentage of post-issue shareholding of proposed allottee

Preferential Allotment Details

• Proposed preferential allotment to promoter Karthikeya Manchala
• Pre-issue shareholding: 650,000 shares (4.42%)
• Proposed allotment: 700,000 warrants
• Post-issue shareholding: 1,350,000 shares (8.75%)

Impact on Shareholding

• Promoter shareholding increases from 4.42% to 8.75% post-issue

Capital Raising and Shareholding Changes

• Issue of up to 700,000 fully convertible warrants to promoter Mr. Karthikeya Manchala at Rs. 84 each (special resolution).
• Warrants convertible into equity shares within 18 months; 25% payment on allotment, balance on conversion; subject to lock-in.
• Promoter holding to increase from 63.09% to 64.76% assuming full conversion; no change in control.
• Preferential issue proceeds of Rs. 5.88 crore intended for working capital (Rs. 5 crore) and general corporate purposes (Rs. 0.88 crore).
• Warrants and resulting shares to be dematerialized and listed on BSE; only promoter subscribes.

Board and Management Changes ️

• Re-appointment of Mr. M. Satyendra as Chairman & Managing Director for 3 years from May 14, 2026 (special resolution).
• Proposed remuneration Rs. 10,00,000 per month with minimum remuneration applicable if profits are inadequate.
• Mr. M. Satyendra holds 47.52% shares; re-appointment supported by Nomination and Remuneration Committee.

Related Party Transactions ️

• Approval for material related party transactions with subsidiary Medley Medical Solutions Pvt Ltd up to Rs. 60 crore per year for FY 2025-26 and 2026-27 (ordinary resolution).
• Transactions include purchase/sale of services, software development, investments, and inter-corporate loans on arm’s length basis.
• Audit Committee and Board approved related party transactions; related parties abstained from voting.